Sell & buySold some MEG & bought 400 CVE.
At this price CVE is a long term winner but selling MEG at a loss of over 41/share hurts.
We have to look at the long term & be confident that the top management of CVE have this figured out properly, as to the benefits to be gained from taking over HSE, which has a poor record on the retail end.